ArticleChemical science2026
Conformational landscapes resolved by ion mobility mass spectrometry reveal mechanisms of polyubiquitin-controlled phase separation.
Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Polyubiquitin chains regulate phase separation of the ubiquitin-binding shuttle protein ubiquilin-2 (UBQLN2) in a manner that depends on the position of the isopeptide linkage and the length of the polyubiquitin chain. However, conformational heterogeneity of the non-covalent complexes formed between these proteins has rendered the molecular mechanisms underlying this regulation elusive. Here, we have used ion mobility mass spectrometry (IM-MS) to disentangle conformational features of the non-covalent complexes formed by UBQLN2 with different polyubiquitin chains. We demonstrate that the length of the polyubiquitin chain binding to UBQLN2 has a large effect on the conformational distribution of the complex, with increasing chain lengths (up to four ubiquitin subunits) allowing access to more extended conformations of the complex, and shorter chains promoting compaction. This length-dependent modulation of conformational landscapes provides the evidence for distinct mechanisms of phase separation regulation encoded by ubiquitin chain length. We also compare polyubiquitin chains linked by lysine residue (K)48 and by K63, both alone and in complex with UBQLN2. By understanding how K48- and K63-linked tetraubiquitin chains behave in the gas phase, which differs to solution, we propose molecular mechanisms for their regulation of UBQLN2 phase separation. This work, enabled by the unique ability of IM-MS to resolve conformational features of highly heterogeneous biomolecular systems, represents a conceptual breakthrough in understanding polyubiquitin-controlled phase separation mechanisms.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.